Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 12 | 2013 | 621 | 2.430 |
Why?
|
| Biomarkers, Tumor | 8 | 2013 | 1670 | 1.000 |
Why?
|
| Diagnosis, Differential | 14 | 2022 | 1615 | 0.810 |
Why?
|
| Neurothekeoma | 2 | 2012 | 5 | 0.720 |
Why?
|
| Chancre | 1 | 2020 | 2 | 0.660 |
Why?
|
| Syphilis, Cutaneous | 1 | 2020 | 3 | 0.660 |
Why?
|
| Treponema pallidum | 1 | 2020 | 8 | 0.660 |
Why?
|
| Skin Diseases | 2 | 2012 | 176 | 0.650 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 71 | 0.640 |
Why?
|
| Rectum | 1 | 2020 | 151 | 0.610 |
Why?
|
| Skin | 2 | 2020 | 605 | 0.600 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2019 | 7 | 0.590 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 1827 | 0.590 |
Why?
|
| Conjunctival Diseases | 1 | 2018 | 6 | 0.580 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 21 | 0.580 |
Why?
|
| Orbital Diseases | 1 | 2018 | 15 | 0.580 |
Why?
|
| Hernia | 1 | 2018 | 23 | 0.580 |
Why?
|
| Drug Eruptions | 1 | 2018 | 35 | 0.540 |
Why?
|
| Adipose Tissue | 1 | 2018 | 271 | 0.480 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 825 | 0.460 |
Why?
|
| Sarcoma | 2 | 2007 | 224 | 0.460 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 224 | 0.460 |
Why?
|
| Receptors, IgE | 1 | 2015 | 6 | 0.460 |
Why?
|
| Penile Neoplasms | 2 | 2022 | 19 | 0.450 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 44 | 0.450 |
Why?
|
| Urticaria | 1 | 2015 | 15 | 0.450 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 2011 | 23 | 0.420 |
Why?
|
| Autoantibodies | 1 | 2015 | 281 | 0.410 |
Why?
|
| Meningioma | 1 | 2013 | 68 | 0.380 |
Why?
|
| Handwriting | 1 | 2012 | 6 | 0.380 |
Why?
|
| Medical Audit | 1 | 2012 | 41 | 0.370 |
Why?
|
| Middle Aged | 17 | 2022 | 28208 | 0.370 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2012 | 13 | 0.370 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 14 | 0.370 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 162 | 0.370 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1425 | 0.360 |
Why?
|
| Aged | 15 | 2022 | 20848 | 0.350 |
Why?
|
| Indoles | 1 | 2013 | 317 | 0.350 |
Why?
|
| DNA, Viral | 1 | 2012 | 272 | 0.350 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 301 | 0.350 |
Why?
|
| Bowen's Disease | 1 | 2011 | 9 | 0.340 |
Why?
|
| Lipoma | 1 | 2011 | 27 | 0.340 |
Why?
|
| Paget Disease, Extramammary | 1 | 2011 | 8 | 0.340 |
Why?
|
| Neoplasms, Second Primary | 1 | 2013 | 245 | 0.340 |
Why?
|
| Sulfonamides | 1 | 2013 | 337 | 0.340 |
Why?
|
| Alopecia | 2 | 2021 | 35 | 0.340 |
Why?
|
| Herpes Simplex | 1 | 2012 | 203 | 0.340 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 57 | 0.330 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 53 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 1346 | 0.330 |
Why?
|
| Male | 18 | 2022 | 45686 | 0.320 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2010 | 22 | 0.320 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2009 | 3 | 0.310 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 7215 | 0.310 |
Why?
|
| Female | 18 | 2021 | 49872 | 0.310 |
Why?
|
| Leiomyoma | 1 | 2013 | 211 | 0.310 |
Why?
|
| Collagen | 1 | 2011 | 306 | 0.300 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 125 | 0.300 |
Why?
|
| Humans | 27 | 2022 | 95802 | 0.300 |
Why?
|
| Arm | 1 | 2009 | 100 | 0.290 |
Why?
|
| Melanoma | 1 | 2013 | 495 | 0.290 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2010 | 149 | 0.290 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2008 | 2 | 0.280 |
Why?
|
| Glomus Tumor | 1 | 2008 | 10 | 0.280 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 28 | 0.280 |
Why?
|
| Electronic Health Records | 1 | 2012 | 372 | 0.280 |
Why?
|
| Nipples | 1 | 2008 | 38 | 0.280 |
Why?
|
| Leg | 1 | 2008 | 143 | 0.270 |
Why?
|
| Neoplasms, Bone Tissue | 1 | 2007 | 2 | 0.260 |
Why?
|
| Buttocks | 1 | 2007 | 10 | 0.260 |
Why?
|
| Adult | 11 | 2022 | 28578 | 0.260 |
Why?
|
| CD56 Antigen | 1 | 2007 | 18 | 0.260 |
Why?
|
| Leiomyosarcoma | 1 | 2007 | 48 | 0.260 |
Why?
|
| Fibroma | 1 | 2007 | 33 | 0.260 |
Why?
|
| CD4 Antigens | 1 | 2007 | 82 | 0.250 |
Why?
|
| Leukemia, Myeloid | 1 | 2008 | 240 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 366 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2006 | 10 | 0.240 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 557 | 0.230 |
Why?
|
| Transcription Factors | 1 | 2013 | 1730 | 0.230 |
Why?
|
| Biopsy | 3 | 2020 | 1208 | 0.220 |
Why?
|
| Hematologic Neoplasms | 1 | 2007 | 372 | 0.190 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2022 | 4 | 0.190 |
Why?
|
| Vascular Neoplasms | 1 | 2022 | 21 | 0.190 |
Why?
|
| Ustekinumab | 1 | 2021 | 52 | 0.170 |
Why?
|
| Young Adult | 4 | 2022 | 7026 | 0.170 |
Why?
|
| Child | 3 | 2019 | 7618 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 1192 | 0.150 |
Why?
|
| Sampling Studies | 1 | 2018 | 76 | 0.140 |
Why?
|
| Illinois | 1 | 2020 | 530 | 0.140 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2018 | 23 | 0.140 |
Why?
|
| Psoriasis | 1 | 2021 | 254 | 0.140 |
Why?
|
| Lichenoid Eruptions | 1 | 2018 | 3 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 241 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 231 | 0.140 |
Why?
|
| Granuloma | 1 | 2018 | 65 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 150 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 930 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 188 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2010 | 547 | 0.120 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 481 | 0.120 |
Why?
|
| Lichen Planus | 1 | 2015 | 10 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1805 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2018 | 285 | 0.120 |
Why?
|
| Scalp | 1 | 2015 | 72 | 0.110 |
Why?
|
| Actins | 2 | 2008 | 472 | 0.110 |
Why?
|
| Mast Cells | 1 | 2015 | 97 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1798 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3155 | 0.110 |
Why?
|
| Eosinophils | 1 | 2015 | 196 | 0.110 |
Why?
|
| Neutrophils | 1 | 2015 | 328 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 257 | 0.100 |
Why?
|
| Chickenpox | 1 | 2012 | 37 | 0.090 |
Why?
|
| Herpesvirus 3, Human | 1 | 2012 | 39 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 336 | 0.090 |
Why?
|
| Adolescent | 3 | 2021 | 9873 | 0.090 |
Why?
|
| Herpes Zoster | 1 | 2012 | 80 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 848 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2013 | 302 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 983 | 0.090 |
Why?
|
| Simplexvirus | 1 | 2012 | 150 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 299 | 0.090 |
Why?
|
| PAX8 Transcription Factor | 1 | 2010 | 24 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 50 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2012 | 166 | 0.080 |
Why?
|
| Mucin-1 | 1 | 2010 | 46 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2061 | 0.080 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 163 | 0.080 |
Why?
|
| Ki-1 Antigen | 1 | 2009 | 19 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 255 | 0.080 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2009 | 107 | 0.070 |
Why?
|
| Collagen Type IV | 1 | 2008 | 28 | 0.070 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2008 | 11 | 0.070 |
Why?
|
| Muramidase | 1 | 2008 | 37 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 54 | 0.070 |
Why?
|
| Mitosis | 1 | 2008 | 152 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2008 | 288 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 32 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 1079 | 0.060 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 19 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2008 | 480 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 618 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 1194 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2012 | 3970 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2008 | 9167 | 0.050 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 97 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2018 | 10273 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2006 | 908 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1662 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2006 | 480 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1275 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 1087 | 0.050 |
Why?
|
| Penis | 1 | 2022 | 65 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2039 | 0.040 |
Why?
|
| Disease Progression | 1 | 2006 | 1559 | 0.040 |
Why?
|
| Pregnancy | 1 | 2008 | 3237 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 2042 | 0.040 |
Why?
|
| Prognosis | 1 | 2007 | 3990 | 0.040 |
Why?
|
| Extremities | 1 | 2015 | 179 | 0.030 |
Why?
|
| Keratins | 1 | 2009 | 63 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 53 | 0.020 |
Why?
|